The growth of Flamingo Biolab during the last fiscal year has been a reflection of the momentum behind Andalusian biotechnology entrepreneurship. In statements to Diario de Córdoba, our CEO, Luis Martínez, highlighted the current evolution:

“The company is growing; we have gone from one employee last year to seven in January.”

In a sector as demanding and highly specialized as biotechnology applied to healthcare, Flamingo Biolab has managed to consolidate a technical structure capable of developing medical digital twins and advanced surgical planning solutions.

The case of Flamingo shows the importance of consolidating a solid business framework in Cordoba. The capacity to attract qualified talent and develop technology-based projects is, today, a decisive factor in competing successfully within the Andalusian tech sector.

The growth recorded in this first quarter reinforces Flamingo Biolab’s commitment to strengthening its presence in the healthcare field, banking on a business model based on efficiency, the development of intellectual property, and the creation of highly qualified employment in the region.

You can read more about the article at the following link.